NASDAQ · Analyst Forecast

Tempest Therapeutics, Inc. (TPST) Stock Forecast & Price Target

$0.33 NASDAQ: TPST Market Cap $6.54M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Tempest Therapeutics, Inc. (TPST), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Tempest Therapeutics, Inc., analysts forecast revenue rising from $137,789 in 2021 to $117.70M in 2029; the average estimate for 2029 earnings per share is −$4.23; 14 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2021$110,230$137,789$165,34714
2025$0$0$01
2026$17.85M$17.85M$17.85M1
2027$57.82M$57.82M$57.82M1
2028$4.30M$4.30M$4.30M1
2029$117.70M$117.70M$117.70M1

Earnings per share forecast

YearLowAverageHighAnalysts
2021−$83.37−$83.37−$83.3714
2025−$6.10−$6.10−$6.101
2026−$2.85−$2.85−$2.851
2027−$0.90−$0.90−$0.901
2028−$0.89−$0.89−$0.891
2029−$4.23−$4.23−$4.231

Tempest Therapeutics, Inc. (TPST) forecast — frequently asked questions

What are analysts forecasting for Tempest Therapeutics, Inc.'s earnings?

The average analyst estimate for Tempest Therapeutics, Inc. (TPST) earnings per share in 2029 is -4.23, with individual estimates between -4.23 and -4.23.

How much revenue is Tempest Therapeutics, Inc. expected to make?

Analysts forecast Tempest Therapeutics, Inc. (TPST) revenue of $117.70M in 2029, based on 1 published estimates.

How many analysts cover TPST?

14 analysts contribute estimates for Tempest Therapeutics, Inc. (TPST). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.